TheEdgeResearch
Home / Stocks / LVVV

LiveWire Ergogenics, Inc. (LVVV)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$761,592
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.39
52-Wk Range
0.0001-0.002
CEO
William J. Hodson
Country
US
Currency
USD

LiveWire Ergogenics, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Anaheim, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $761,592. On trailing twelve-month figures it carries a trailing P/E of -0.49, a net margin of -3327.5%. Its beta of 0.39 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.49
Price / Sales
16.44
Price / Book
-0.40
EV / EBITDA
-40.79
Gross margin
33.0%
Operating margin
-290.7%
Net margin
-3327.5%
Return on equity
Debt / equity
-1.98
Current ratio
0.02
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2009-09-08
Headquarters
Anaheim, CA, US
About LiveWire Ergogenics, Inc.

LiveWire Ergogenics, Inc. (LVVV) focuses on developing and overseeing specialized real estate holdings, which it then licenses for the cultivation and production of artisanal, organically grown cannabis items. These premium products are intended for both therapeutic use and recreational adult consumption within the state of California. The company's main operational hub is situated in Anaheim, California.

Comparable companies

LiveWire Ergogenics, Inc. is most often compared with the following Healthcare names:

ANTCFCVGRFEVIOGENPFHEMPIGEXKAYSLVRLFMCOATLLTF
More research on LVVV
LVVV technical analysis LVVV TheEdge Score Compare against peers
Open full interactive analysis & DCF →